Review 2023 · 3 citations

Vaccination in Individuals with Multiple Sclerosis - Part II

Tuncer, Asli, Cinar, Bilge Piri, Bilge, Nuray, Bunul, Sena Destan, Gozubatik-Celik, Rabia Gokcen, Ciftci, Eda Derle, Genc, Gencer, Karaman, Bedriye, Kilic, Ahmet Kasim, Sariteke, Alp, Seferoglu, Meral, Sivaci, Ali Ozhan, Tiftikcioglu, Bedile Irem, Tunc, Abdulkadir, Uncu, Gulgun, Yavas, Irfan, Yetkin, Mehmet Fatih, Efendi, Husnu, Siva, Aksel

Abstract

Multiple sclerosis (MS) is an autoimmune and demyelinating disease of the central nervous system. It is a chronic disease, and in the evaluation of all other health and vital processes, decisions about vaccination should be made considering the disease process and the medications used by the patient. Since vaccination can be performed at any stage of life, immune system activity should be reviewed in patients with MS except where it is characteristic of the vaccine. In this review, the applications of different vaccines in patients with MS are discussed in two separate sections (part 1 was published in the previous issue).

Keywords

Multiple sclerosis vaccination safety BORNE ENCEPHALITIS VACCINE YELLOW-FEVER VACCINATION ORAL POLIOVIRUS VACCINE INFLUENZA VACCINATION RISK-FACTORS IMMUNIZATION PRACTICES SEASONAL INFLUENZA ADVISORY-COMMITTEE ROUTINE USE SAFETY

WoS Categories

Clinical Neurology

Sustainable Development Goals

Good Health and Well-being

Citation

Journal: TURKISH JOURNAL OF NEUROLOGY
Year: 2023
Volume: 29
Issue: 2
Pages: 85-94
ISSN: 1301-062X
eISSN: 1309-2545
DOI: 10.4274/tnd.2023.16984
WoS UID: WOS:001029658500001

Open via DOI